CRBG
Corebridge Financial, Inc.
CRBG's fundamentals are strong: its operating margin rose 9 points to 17% and revenue grew 13%. At 8.0x earnings, it's trading below its usual 9.8x. Analysts expect strong earnings growth, though they disagree widely on how much.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
CRBG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
CRBG's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like CRBG.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
CRBG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 6.7x | $35.97 | — |
| Cheap | 7.4x | $33.58 | -6.6% |
| Current | 8x | $35.97 | — |
| Fair | 9.6x | $43.16 | +20% |
| Expensive | 29x | $130 | +262% |
Historical ranges are pointers, not guarantees.
CRBG's PE is in its cheap range at 8.0x. If earnings grow as analysts expect, today's price would be 6.7x next year's earnings.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
CRBG Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CRBG's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CRBG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.39 | +19% |
| Q3 2026 | $4.51 | +178% |
| Q2 2026 | $1.56 | +$2.23 |
| Q1 2026 | $0.40 | -64% |
| Q4 2025 | -$0.68 | -118% |
| Q3 2025 | $1.62 | +$3.69 |
| Q2 2025 | -$0.67 | -121% |
| Q1 2025 | $1.12 | -71% |
| Q4 2024 | $3.72 | +118% |
CRBG has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
CRBG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6.2B | +14% |
| Q2 2026 | $3.9B | +43% |
| Q1 2026 | $4B | +10% |
| Q4 2025 | $6.8B | +2.2% |
| Q3 2025 | $5.4B | +107% |
| Q2 2025 | $2.7B | -26% |
| Q1 2025 | $3.6B | -38% |
| Q4 2024 | $6.6B | +97% |
CRBG's revenue has grown year over year for five quarters in a row: $6.2B last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 38% | +39 points |
| Q2 2026 | 1.3% | +24 points |
| Q1 2026 | 2.5% | +27 points |
| Q4 2025 | 14% | -30 points |
| Q3 2025 | -0.8% | +60 points |
| Q2 2025 | -22% | -35 points |
| Q1 2025 | -24% | -41 points |
| Q4 2024 | 44% | +97 points |
CRBG has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
CRBG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $605M | +2421% |
| Q2 2026 | -$44M | +$215M |
| Q1 2026 | -$9M | -102% |
| Q4 2025 | $1.9B | +27% |
| Q3 2025 | $24M | -71% |
| Q2 2025 | -$259M | -$250M |
| Q1 2025 | $375M | -37% |
| Q4 2024 | $1.5B | +93% |
CRBG has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
CRBG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -7M shares |
| 1 year | -17% | -93.4M shares |
| 3 years | -30% | -194M shares |
CRBG has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $185M |
| Q2 2026 | $300M |
| Q1 2026 | $1.3B |
| Q4 2025 | $1.1B |
| Q3 2025 | $380M |
| Q2 2025 | $311M |
| Q1 2025 | $321M |
| Q4 2024 | $398M |
CRBG spent $2.8B buying back its own shares over the past year, up 101% from the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CRBG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | 360.7x | High |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -1.3x | Net Cash |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 1.9x | Healthy |
CRBG's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago. Net leverage isn't a meaningful measure for financial services companies like CRBG.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
CRBG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.8 | Neutral |
| Stochastic | 72.5 | Neutral |
CRBG's weekly RSI is 66 (neutral) and its Stochastic is 73 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
CRBG PE vs Financial Services Sector
| Metric | CRBG | Sector median | Relative |
|---|---|---|---|
| PE | 8x | 13x | 39% below |
| PE % | 29 | 57 | 28 pts below |
CRBG is trading at 8.0x earnings, a 39% discount to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
CRBG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.6 | 4.1% above |
| 20 week MA | $33.4 | 7.7% above |
| 50 week MA | $30.2 | 19% above |
| 100 week MA | $31.1 | 16% above |
| 200 week MA | $27.3 | 32% above |
CRBG has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
CRBG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $20.7 | $20.3 | -2.2% |
| 2023 | $20.3 | $21.7 | +6.9% |
| 2024 | $21.7 | $30.0 | +39% |
| 2025 | $30.0 | $30.6 | +1.9% |
| 2026 YTD | $30.6 | $36.0 | +18% |
CRBG has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.